SCHEMBL25980314

SCHEMBL25980314

c1ccc(-c2ccc(-c3cc(-c4ccccc4)nc(-c4ccc5c(c4)oc4c(N(c6ccccc6)c6ccc(-c7ccccc7)cc6)cccc45)n3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.37
MEN1 O00255 9/20 0.37
ALDH1A1 P00352 8/20 0.37
MAPT P10636 7/20 0.37
HPGD P15428 7/20 0.37
KDM4E B2RXH2 5/20 0.37
LMNA P02545 3/20 0.37
NTSR1 P30989 1/20 0.36
GLA P06280 1/20 0.35
DHODH Q02127 1/20 0.32
POLB P06746 2/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32
PTPRF P10586 1/20 0.32
PTPN2 P17706 1/20 0.32
PTPN1 P18031 1/20 0.32
ADORA2A P29274 2/20 0.31
ADORA1 P30542 2/20 0.31
NPSR1 Q6W5P4 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25980299 1.00 KMT2A (0.37) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL26416749 0.99 KMT2A (0.38) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL25980291 0.97 KMT2A (0.40) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL25980278 0.97 KMT2A (0.40) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL25980277 0.97 KMT2A (0.40) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL25980317 0.94 CYP1A1 (0.40) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL25980257 0.93 MAPT (0.35) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL25980061 0.93 MAPT (0.35) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL25980276 0.93 MAPT (0.35) KMT2AMEN1ALDH1A1MAPTHPGD
SCHEMBL25979998 0.93 MAPT (0.35) KMT2AMEN1ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 KMT2A 758/4885MEN1 257/4885ALDH1A1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.